Search filters

List of works by Lung-Yi Mak

A large real-world cohort study examining the effects of long-term entecavir on hepatocellular carcinoma and HBsAg seroclearance

scientific article published on 09 December 2019

An update on the toxicological considerations for protease inhibitors used for hepatitis C infection.

scientific article

Association Between Hepatic Steatosis, Measured by Controlled Attenuation Parameter, and Fibrosis Burden in Chronic Hepatitis B.

scientific article published on 29 September 2017

Association of adipokines with hepatic steatosis and fibrosis in chronic hepatitis B patients on long-term nucleoside analogue

scientific article published on 11 April 2019

Correlation of serum Mac-2-binding protein glycosylation isomer (M2BPGi) and liver stiffness in chronic hepatitis B infection

scientific article published on 22 January 2019

DNA polymerase inhibitors for treating hepatitis B: a safety evaluation.

scientific article

Direct Health Care Cost Utilization in Hong Kong Inflammatory Bowel Disease Patients in the Initial 2 Years Following Diagnosis.

scientific article published on 5 May 2017

Editorial: can hepatitis B core-related antigen be the new biomarker for hepatocellular carcinoma in nucleoside analogue-treated chronic hepatitis B?

scientific article published on 01 April 2019

Editorial: liver and kidney injury from remdesivir—an issue not as much as its purpose. Authors' reply

Entecavir Reduced Serum Hepatitis B Core-Related Antigen in Chronic Hepatitis B Patients with Hepatocellular Carcinoma

scientific article published on 29 May 2020

Epidemiology and natural history of Wilson's disease in the Chinese: A territory-based study in Hong Kong between 2000 and 2016.

scientific article published in November 2017

Fibrosis evolution in chronic hepatitis B e antigen-negative patients across a 10-year interval

scientific article published on 16 April 2019

HBV RNA profiles in chronic hepatitis B patients under different disease phases and anti-viral therapy

scientific article published on 06 November 2020

Hepatitis B core protein as a therapeutic target.

scientific article

Hepatitis B core-related antigen levels after HBeAg seroconversion is associated with the development of hepatocellular carcinoma

scientific article published on 02 September 2019

Inverse relationship between hepatic steatosis and hepatitis B viremia: Results of a large case-control study.

scientific article published on 3 August 2017

Letter: serum HBcrAg is a useful marker for disease monitoring, predicting treatment response and disease outcome of chronic hepatitis B virus infection-authors' reply

scientific article published on 01 June 2018

Long Term Outcomes and Predictive Scores for Hepatocellular Carcinoma and HBsAg Seroclearance after HBeAg Seroclearance.

scientific article

Model for End-stage Liver Disease with additional criteria to predict short-term mortality in severe flares of chronic hepatitis B

scientific article published on 23 December 2019

Pharmacokinetic evaluation of besifovir for the treatment of HBV infection

scientific article published on 13 December 2017

Prediction of hepatocellular carcinoma development by aminotransferase to platelet ratio index in primary biliary cholangitis

scientific article published in November 2017

Remdesivir use and risks of acute kidney injury and acute liver injury among patients hospitalised with COVID ‐19: a self‐controlled case series study

Reply to "Can the ratio of serum HBV RNA to DNA reflect the reverse transcription efficiency of viral pgRNA?"

scientific article published on 23 December 2020

Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection.

scientific article published on 16 October 2017

Risk of acute liver injury following the nirmatrelvir/ritonavir use

Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation

scientific article published on 05 August 2020

Role of serum M2BPGi levels on diagnosing significant liver fibrosis and cirrhosis in treated patients with chronic hepatitis B virus infection.

scientific article published on 19 June 2018

Serum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patients.

scientific article published on 20 February 2019

The role of interleukin-27 in predicting spontaneous HBeAg seroconversion in chronic hepatitis B infection

scientific article published on 23 January 2017

Trends in liver transplantation for chronic hepatitis B in the era of highly potent antiviral therapies over the past two decades

scientific article published on 11 July 2020

Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts liver cancer development in chronic hepatitis B patients under antiviral treatment

scientific article published on 7 May 2017

Paulina is supported by:

About Paulina

Help